74 FR 192 pgs. 51288-51289 - Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications
Type: NOTICEVolume: 74Number: 192Pages: 51288 - 51289
Docket number: [Docket Nos. FDA-2009-M-0033, FDA-2009-M-0016, FDA-2009-M-0034, FDA-2009-M-0049, FDA-2009-M-0071, FDA-2009-M-0127, FDA-2009-M-0128, FDA-2009-M-0135, FDA-2009-M-0159]
FR document: [FR Doc. E9-23962 Filed 10-5-09; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2009-M-0033, FDA-2009-M-0016, FDA-2009-M-0034, FDA-2009-M-0049, FDA-2009-M-0071, FDA-2009-M-0127, FDA-2009-M-0128, FDA-2009-M-0135, FDA-2009-M-0159]
Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is publishing a list of premarket approval applications (PMAs) that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMAs through the Internet and the agency's Division of Dockets Management.
ADDRESSES:
Submit written requests for copies of summaries of safety and effectiveness data to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number as listed in table 1 of this document when submitting a written request. See the SUPPLEMENTARY INFORMATION section for electronic access to the summaries of safety and effectiveness.
FOR FURTHER INFORMATION CONTACT:
Nicole Wolanski, Center for Devices and Radiological Health (HFZ-402), Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 1650, Silver Spring, MD 20993, 301-796-6570.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of January 30, 1998 (63 FR 4571), FDA published a final rule that revised 21 CFR 814.44(d) and 814.45(d) to discontinue individual publication of PMA approvals and denials in the Federal Register . Instead, the agency now posts this information on the Internet on FDA's home page at http://www.fda.gov . FDA believes that this procedure expedites public notification of these actions because announcements can be placed on the Internet more quickly than they can be published in the Federal Register , and FDA believes that the Internet is accessible to more people than the Federal Register .
In accordance with section 515(d)(4) and (e)(2) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360e(d)(4) and (e)(2)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the act. The 30-day period for requesting reconsideration of an FDA action under § 10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30-day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30-day period will begin when the applicant is notified by FDA in writing of its decision.
The regulations provide that FDA publish a quarterly list of available safety and effectiveness summaries of PMA approvals and denials that were announced during that quarter. The following is a list of approved PMAs for which summaries of safety and effectiveness were placed on the Internet from January 1, 2009, through March 31, 2009. There were no denial actions during this period. The list provides the manufacturer's name, the product's generic name or the trade name, and the approval date.
| PMA No. Docket No. | Applicant | Trade Name | Approval Date |
|---|---|---|---|
| P060030 FDA-2009-M-0033 | Roche Molecular Systems, Inc. | Cobas ampliprep/cobas taqman HFC test | October 30, 2008 |
| P950009 (S8) FDA-2009-M-0016 | BD Diagnostics | BD focal point gs imaging system | December 3, 2008 |
| P080010 FDA-2009-M-0034 | Advanced Medical Optics, Inc. | Tecnis multifocal foldable posterior chamber intraocular lens | January 16, 2009 |
| P080021 FDA-2009-M-0049 | Advanced Vision Science, Inc. | xact foldable hydrophobic acrylic UV light absorbing posterior chamber IOL | February 2, 2009 |
| P030031 (S11) FDA-2009-M-0071 | Biosense Webster, Inc. | Navistar Celsius thermo cool catheters | February 6, 2009 |
| P070014 FDA-2009-M-0127 | Bard Peripheral Vascular, Inc. | lifestent flexstar flexstar XL vascular stent system | February 13, 2009 |
| P940015 (S12) FDA-2009-M-0128 | Genzyme Corp. | Synvisc-One | February 26, 2009 |
| P070005 FDA-2009-M-0135 | Synthemed Corp. | Repel-cv bioresorbable adhesion barrier | March 6, 2009 |
| P080002 FDA-2009-M-0159 | The Female Health Co. | FC2 female condom | March 10, 2009 |
II. Electronic Access
Persons with access to the Internet may obtain the documents at http://www.fda.gov/cdrh/pmapage.html.
Dated: September 24, 2009.
Jeffrey Shuren,
Acting Director, Center for Devices and Radiological Health.
[FR Doc. E9-23962 Filed 10-5-09; 8:45 am]
BILLING CODE 4160-01-S